Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 814 results for "copd"

New standards to avoid vocational Chronic Obstructive Pulmonary Disease (COPD)
HR Director

Non-intrusive Ventilation Offers Lifeline for COPD-inflicted P...

THIRUVANANTHAPURAM: When a patient is afflicted with COPD, a disease that prevents free flow of oxygen to lungs, there is little chance to bring him/her back to normalcy. If there is any, that is through Non-invasive Ventilation(NIV). Sadly, most ... New Indian Express, 4 hours ago
[x]  

98 images for copd

Monthly Prescribing Reference, 2 days ago
Pharmaceutical Journal, 20 hours ago
European Pharmaceutical Review, 2 days ago
Vermont Public Radio, 1 day ago
Virtual Strategy Magazine, 11 hours ago
MDLinx, 13 hours ago
European Pharmaceutical Review, 18 hours ago
NewsReality.com, 22 hours ago
NewsReality.com, 22 hours ago
NewsReality.com, 22 hours ago

Challenge remains for early COPD detection in primary care

medwireNews: Exhaled carbon monoxide (eCO) testing in primary care has no effect on patient acceptance of screening for chronic obstructive pulmonary disease (COPD), research shows. The findings also show that the method a simple means to assess ...
 MedWire News22 hours ago
EuroInvestor

Novartis' duo of COPD drugs clears Phase III on the path to an FDA decision

Novartis ($NVS), working to get a pair of Europe-approved COPD treatments onto the U.S. market, reported some positive Phase III data while awaiting final word from the FDA. The two inhaled treatments are NVA237, a bronchodilator marketed as ...
 FierceBiotech18 hours ago Novartis kann zwei Phase-III-Studien für COPD-Medikamente erfolgreich beenden  Swissquote2 days ago Novartis announces two positive US phase III programs in COPD for QVA149 and NVA237  EuroInvestor2 days ago Novartis Reports Two Positive US Phase III Programs In COPD For QVA149, NVA237  RTTNews.com2 days ago
[x]  
NigerianHerald.com

Rural poor at higher risk for COPD, researchers say

iStock New research backs previous findingsthat being poor and living in a rural area are risk factors forchronic obstructive pulmonary disease (COPD). COPD is a progressive deteriorationof the lungsthat develops slowly and gets worse over ...
 UnitedHealthcare1 day ago Antidepressants Ease Postpartum Depression, Study Finds  NigerianHerald.com2 days ago Rural Poor Bear Higher Burden of COPD, Study Finds  US News & World Report3 days ago COPD is more prevalent in poor and rural areas of the US  EurekAlert!3 days ago
[x]  

Market Assessment of Respiratory Diagnostics in the United States and Europe

Diagnosis of Lung Cancer and COPD is Driving the Market This research service provides an analysis of the respiratory imaging diagnostics market in the United States and Europe. The service provides detailed analysis of the current and ...
 Frost & Sullivan2 days ago Respiratory Disease Testing Market Expected to Reach USD 3.1 Billion Globally in 2022: Transparency Market Research  Digital Journal2 days ago

Non-coding RNAs in the pathogenesis of COPD

1 , Pieter Mestdagh 2 , Jo Vandesompele 2 , Guy G Brusselle 1 , Ken R Bracke 1 1 Laboratory for Translational Research in Obstructive Pulmonary Diseases, Department of Respiratory Medicine , Ghent University Hospital , Ghent , Belgium 2 ...
 British Journal of the Thorax2 days ago

Non-invasive Ventilation is effective for COPD

Comment · print · T T T+· T- Photo: By Arrangement Pulmonologist, Vivek Nangia. TOPICS Expert says NIV is very effective in reducing the CO2 levels in the blood of patients. Non-invasive Ventilation (NIV) in which breathing is ...
 The Hindu3 days ago

BET 1: use of a procalcitonin algorithm to guide antimicrobial therapy in COPD exacerbations can reduce antibiotic consumption with no increase in rates of treatment failure or mortality

Abstract A shortcut review was carried out to establish whether a procalcitonin-guided algorithm could safely reduce antibiotic consumption for patients with an exacerbation of chronic obstructive pulmonary disease ...
 Emergency Medicine Journal3 days ago
PRWeb

Chronic Obstructive Pulmonary Disorder Therapeutics Market Discussed in In-demand FirstWord Report Published at MarketPublishers.com

In-demand research report "Chronic Obstructive Pulmonary Disorder (COPD): KOL Insight" created by FirstWord is now available at MarketPublishers.com. London, UK (PRWEB) May 22, 2015 Combination therapy, or polytherapy, will likely become the ...
 Benzinga.com15 hours ago
[x]  

Theravance Biopharma Presents Additional Positive Phase 2b Study Data on TD-4208 for Treatment of COPD at American Thoracic Society 2015 International Conference

GEORGE TOWN, GRAND CAYMAN -- (Marketwired) -- 05/20/15 -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today announced the presentation of additional positive data from its Phase 2b dose-ranging study of ...
 Pettinga Financial Advisors2 days ago THERAVANCE BIOPHARMA : Presents Additional Positive Phase 2b Study Data on TD-4208 for Treatment of COPD at American Thoracic Society 2015 International Conference  4 Traders2 days ago Theravance Biopharma reports lower Q1 net loss, provides annual outlook  Individual.com15 hours ago Theravance Biopharma's TD-4208 successful in lung disease study  Seeking Alpha2 days ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less